Pretreatment of Cisplatin in recipients attenuates Post-Transplantation Pancreatitis in murine model

International Journal of Biological Sciences

Volumn 8, Issue 3, 2012, Pages 298-309

  Yan, Sheng ^a,b   Ding, Yuan ^a,b   Sun, Fei ^a,b   Lu, Zhongjie ^a,b   Xue, Liang ^a,b   Liu, Xiangyan ^a,b   Shuai, Mingqi ^a,b   Fang, Chen ^a,b   Wang, Yan ^a,b   Cheng, Hui ^a,b   Zhou, Lin ^a,b   Zheng, Ming H ^a,b,c   Zheng, Shusen ^a,b  

^a BEIJING HOSPITAL   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cisplatin; High motility group box protein 1; Intravital fluorescence microscopy; Ischemia reperfusion injury; Pancreatitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CISPLATIN; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL NUCLEUS; DRUG EFFECT; DRUG SCREENING; FLUORESCENCE MICROSCOPY; GERMFREE ANIMAL; GRAFT REJECTION; MALE; METABOLISM; MICROCIRCULATION; MOUSE; PANCREAS; PANCREAS TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE COMPLICATION; PREMEDICATION; PROTEIN TRANSPORT; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL NUCLEUS; CISPLATIN; DRUG EVALUATION, PRECLINICAL; GRAFT REJECTION; HMGB1 PROTEIN; MALE; MICE; MICE, INBRED BALB C; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; PANCREAS; PANCREAS TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROTEIN TRANSPORT; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84863149436     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3656     Document Type: Article

References (33)

1. Lillehei RC, Idezuki Y, Feemster JA, Dietzman RH, Kelly WD, Merkel FK, et al. Transplantation of stomach, intestine, and pancreas: experimental and clinical observations. Surgery. 1967; 62: 721-41.
2. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967; 61: 827-37.
3. Perosa M, Boggi U, Cantarovich D, Robertson P. Pancreas transplantation outside the USA: an update. Current opinion in organ transplantation. 2011; 16:135-141.
4. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant. 2011; 11: 1226-35.
5. Woeste G, Wullstein C, Meyer S, Usadel KH, Hopt UT, Bechstein WO, et al. Octreotide attenuates impaired microcirculation in postischemic pancreatitis when administered before induction of ischemia. Transplantation. 2008; 86: 961-7.
6. Maglione M, Hermann M, Hengster P, Schneeberger S, Mark W, Obrist P, et al. A novel technique for heterotopic vascularized pancreas transplantation in mice to assess ischemia reperfusion injury and graft pancreatitis. Surgery. 2007; 141: 682-9.
7. Hackert T, Werner J, Uhl W, Gebhard MM, Buchler MW, Schmidt J. Reduction of ischemia/reperfusion injury by antithrombin III after experimental pancreas transplantation. Am J Surg. 2005; 189: 92-7.
8. Serr F, Lauer H, Armann B, Ludwig S, Thiery J, Fiedler M, et al. Sirolimus improves early microcirculation, but impairs regeneration after pancreatic ischemia-reperfusion injury. Am J Transplant. 2007; 7: 48-56.
9. Cardinal J, Pan P, Dhupar R, Ross M, Nakao A, Lotze M, et al. Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury. Hepatology. 2009; 50: 565-74.
10. Liu XY, Xue L, Zheng X, Yan S, Zheng SS. Pancreas transplantation in the mouse. Hepatobiliary & pancreatic diseases international: HBPD INT. 2010; 9: 254-8.
11. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, et al. A better model of acute pancreatitis for evaluating therapy. Annals of surgery. 1992; 215: 44-56.
12. Liu YX, Jin LM, Zhou L, Xie HY, Jiang GP, Wang Y, et al. Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in rats. Transpl Int. 2009; 22: 747-56.
13. Maglione M, Oberhuber R, Cardini B, Watschinger K, Hermann M, Obrist P, et al. Donor pretreatment with tetrahydrobiopterin saves pancreatic isografts from ischemia reperfusion injury in a mouse model. Am J Transplant. 2010; 10: 2231-40.
14. Maglione M, Hermann M, Hengster P, Schneeberger S, Mark W, Obrist P, et al. Tetrahydrobiopterin attenuates microvascular reperfusion injury following murine pancreas transplantation. Am J Transplant. 2006; 6: 1551-9.
15. Katarína Vajdová, Stefan Heinrich, Yinghua Tian, Rolf Graf,and Pierre-Alain Clavien. Ischemic Preconditioning and Intermittent Clamping Improve Murine Hepatic Microcirculation and Kupffer Cell Function after Ischemic Injury. Liver Transplantation. 2004; 10(4): 520-528.
16. Tang D, Kang R, Zeh HJ, 3rd, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxidants & redox signaling. 2011; 14: 1315-35.
17. Allan Tsung, Rohit Sahai, Hiroyuki Tanaka, Atsunori Nakao, Mitchell P. Fink, Michael T. Lotze, Huan Yang, Jianhua Li, Kevin J. Tracey, David A. Geller, Timothy R. Billiar.The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. JEM. 2005; 201:1135-1143.
18. Oberhuber, R.; Maglione, M.; Cardini, B.; Hermann, M.; Obrist, P.; Schneeberger, S.; Margreiter, R.; Pratschke, J.; Werner, E.; Brandacher, G. Tetrahydrobiopterin Administration Prevents Lethal Graft Pancreatitis in A Murine Pancreas Transplantation Model: 2974. Transplantation. 2010; 90: 983.
19. Jon Cardinal, Pinhua Pan, Rajeev Dhupar, Mark Ross, Atsunori Nakao, Michael Lotze, Timothy Billiar, David Geller, Allan Tsung. Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury. Hepatology. 2009; 50:565-574.
20. Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006; 93: 518-30.
21. Sorg H, Lorch B, Jaster R, Fitzner B, Ibrahim S, Holzhueter SA, et al. Early rise in inflammation and microcirculatory disorder determine the development of autoimmune pancreatitis in the MRL/Mp-mouse. Am J Physiol Gastrointest Liver Physiol. 2008; 295: G1274-80.
22. Preissler G, Massberg S, Waldner H, Messmer K. Intermittent capillary perfusion in rat pancreas grafts following shortand long-term preservation in University of Wisconsin solution. Transpl Int. 2006; 19: 325-32.
23. Obermaier R, von Dobschuetz E, Muhs O, Keck T, Drognitz O, Jonas L, et al. Influence of nitric oxide on microcirculation in pancreatic ischemia/reperfusion injury: an intravital microscopic study. Transpl Int. 2004; 17: 208-14.
24. V. Schmitza, K.-D. Schaserb, P. Olschewskia, P. Neuhausa, G. Puhla. In vivo Visualization of Early Microcirculatory Changes following Ischemia/Reperfusion Injury in Human Kidney Transplantation. Eur Surg Res 2008;40:19-25.
25. Pedro Cabrales, Amy G. Tsai and Marcos Intaglietta. Microvascular pressure and functional capillary density in extreme hemodilution with lowand high-viscosity dextran and a low-viscosity Hb-based O carrier. Am J Physiol Heart Circ Physiol. 2004; 287:H363-H373.
26. Keck T, Friebe V, Warshaw AL, Antoniu BA, Waneck G, Benz S, Hopt UT, Fernández-del-Castillo C. Pancreatic proteases in serum induce leukocyte-endothelial adhesion and pancreatic microcirculatory failure. Pancreatology. 2005;5(2-3):241-50.
27. Nolte D, Zeintl H, Steinbauer M, Pickelmann S, Messmer K, et al. Functional capillary density: an indicator of tissue perfusion. International Journal of Microcirculation. 1995, 15(5):244-9.
28. Liu A, Dirsch O, Fang H, Sun J, Jin H, Dong W, et al. HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat. Histochemistry and cell biology. 2011; 135: 443-52.
29. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, et al. HMGB1 contributes to kidney ischemia reperfusion injury. Journal of the American Society of Nephrology: JASN. 2010; 21: 1878-90.
30. Yuan H, Jin X, Sun J, Li F, Feng Q, Zhang C, et al. Protective effect of HMGB1 a box on organ injury of acute pancreatitis in mice. Pancreas. 2009; 38: 143-8.
31. Jon S. Cardinal, Pinhua Pan, Rajeev Dhupar, John Klune, Sung Cho, David A. Geller, Allan Tsung. Cisplatin retains high-mobility group box 1 (HMGB1) intranuclearly and protects against hepatic ischemia reperfusion (I/R) injury. Journal of the American College of Surgeons. 2008;207: S21-S22.
32. Pinhua Pan, Jon Cardinal, Rajeev Dhupar, Matthew R. Rosengart, Michael T. Lotze, David A. Geller, Timothy R. Billiar, Allan Tsung, Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality. Journal of Leukocyte Biology.2009;86: 3625-3632.
33. Jon Cardinal, Pinhua Pan, Allan Tsung. Protective role of cisplatin in ischemic liver injury through induction of autophagy. Autophagy.2009;5: 1211-1212.